Sutent Approved for Rare Pancreatic Cancer
Links shared publicly online about this topic.
- 271total visits
Sutent Approved for Rare Pancreatic Cancer
View full resource at health.yahoo.net
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Diet and Nutrition, Drug, FDA, News
Most Recently Shared on May 24, 2011 at 12:49 am By:
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administratio... http://bit.ly/jHoEuw
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 7:06 am By:
MNT Pancreatic Can Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pancreaticcancer
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 10:54 pm By:
Sutent Approved for Rare Pancreatic Cancer - http://bit.ly/jtQdz9
FDA Approves Sutent for Pancreatic Cancer
onclive.com — “The FDA has approved Sutent (sunitinib) for the treatment of patients with unresectable, locally advanced, or metastatic pancreatic neuroendocrine tumors (pNET)” View full resource at onclive.com
Most Recently Shared on May 23, 2011 at 9:54 pm By:
The FDA has approved Sutent (sunitinib) for unresectable pancreatic neuroendocrine tumors (pNET) http://goo.gl/MnX17
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 23, 2011 at 5:19 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Yahoo health: Sutent Approved for Rare Pancreatic Cancer http://bit.ly/lrohqJ Full http://bit.ly/lP8e3J
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 5:08 pm By:
Drugs and Devices OW OW Health
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 -- U.S. Food and Drug Administration approval o... http://bit.ly/jEXC4f #drug
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:06 am By:
MNT Drug Approvals Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3Wc7 #regulatory
Sutent for Rare Type of Pancreatic Cancer Approved by FDA
disabled-world.com — “Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body” View full resource at disabled-world.com
Most Recently Shared on May 22, 2011 at 9:21 pm By:
Disabled World Health Advocate and Health News
Sutent for Rare Type of Pancreatic Cancer Approved by FDA http://ff.im/-DWIfW
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
medworm.com — “FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy” View full resource at medworm.com
Most Recently Shared on May 21, 2011 at 9:32 pm By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/... http://bit.ly/jR8gOy
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 8:13 am By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNew... http://bit.ly/lGiA67 #drug
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 7:16 am By:
FDA Approves Sutent for Rare Type of Pancreatic Cancer - http://bit.ly/j6v3Lp
Medical News: FDA Okays Sunitinib for Rare Pancreatic Tumors - in Oncology/Hematology, Other Cancers from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved Pfizer's sunitinib (Sutent) to treat advanced pancreatic neuroendocrine tumors (pNET) that cannot be removed by surgery or that have spread to other parts of the bod” View full resource at medpagetoday.com
Most Recently Shared on May 21, 2011 at 12:07 am By:
Hisham Rana, MD Doctor and Physician
News: U.S. #FDA okays Sutent (sunitinib) for rare pancreatic tumors http://bit.ly/j7xlW3 - #health
Late-breaking news: FDA approves new treatment for rare type of pancreatic cancer - - ModernMedicine
modernmedicine.com — “FDA has approved everolimus (Afinitor, Novartis) tablets to treat patients with progressive neuroendocrine tumors of pancreatic origin that cannot be removed by surgery or that have spread to other parts of the body (metastatic).” View full resource at modernmedicine.com
Most Recently Shared on May 9, 2011 at 4:21 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
FDA approves new treatment for rare type of pancreatic cancer: http://tinyurl.com/3thp4mm
Afinitor (everolimus) For Rare Pancreatic Cancer Approved By FDA
medicalnewstoday.com — “Afinitor (everolimus), a medication for patients with PNET (progressive neuroendocrine tumors) in the pancreas whose tumor cannot be surgically removed or whose cancer has metastasized (spread), h” View full resource at medicalnewstoday.com
Most Recently Shared on May 7, 2011 at 7:58 pm By:
Endocrinology Wisdom OW Health
Afinitor (everolimus) For Rare Pancreatic Cancer Approved By FDA: Afinitor (everolimus), a medication for patien... http://bit.ly/iUfoZM
Afinitor (everolimus) For Rare Pancreatic Cancer Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “Afinitor (everolimus), a medication for patients with PNET (progressive neuroendocrine tumors) in the pancreas whose tumor cannot be surgically removed or whose cancer has metastasized (spread), has been approved by the Food and Drug Administration (FDA). Neuroendocrine tumors located in the pancreas are rare and grow slowly. According to the CDC, there are approximately 1,000 newly diagnosed cases annually in the USA. Richard Pazdur, M.D...” View full resource at qualitypointtech.net
Most Recently Shared on May 7, 2011 at 4:45 pm By:
Afinitor (everolimus) For Rare Pancreatic Cancer Approved By FDA: Afinitor (everolimus), a medication for patients... http://bit.ly/m7PIP6
Advertisement
